15th Dec 2006 17:27
GlaxoSmithKline PLC15 December 2006 GlaxoSmithKline plc - Voting Rights and Capital In conformity with the Transparency Directive's transitional provision 6 wehereby notify the market of the following: GlaxoSmithKline plc's (GSK) issued share capital consists of 5,991,369,750ordinary shares with voting rights, 232,697,678 ordinary shares of which areheld in Treasury. Therefore, the total number of voting rights in GSK is 5,758,672,072. The above figure (5,758,672,072) may be used by shareholders as the denominatorfor the calculations by which they can determine if they are required to notifytheir interest in, or a change to their interest in GSK under the FinancialServices Authority's Disclosure and Transparency Rules. S M BicknellCompany Secretary 15 December 2006 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline